Public Sector Reimportation Programs Violate FD&C Act, FDA Tells Calif.
Executive Summary
California cannot encourage Rx importation from Canada directly or indirectly without exposing itself to liability under the FD&C Act, FDA told the state Attorney General
You may also be interested in...
FDA Steps Up Campaign Against Rx Imports; Bill “Technically” Flawed
Pending federal legislation to allow importation of prescription drugs from Canada would create unworkable conflicts with state pharmacy laws, FDA Commissioner Mark McClellan told the National Association of Boards of Pharmacy legislative conference Sept. 14 in Washington, D.C
FDA Steps Up Campaign Against Rx Imports; Bill “Technically” Flawed
Pending federal legislation to allow importation of prescription drugs from Canada would create unworkable conflicts with state pharmacy laws, FDA Commissioner Mark McClellan told the National Association of Boards of Pharmacy legislative conference Sept. 14 in Washington, D.C
FDA Import Crackdown Escalates With DoJ Suit Vs. Canadian Pharmacy Site
FDA is escalating its enforcement against drug reimportation through a Department of Justice suit against a Canadian pharmacy operation